Skip to main content
Updated TRICOLORE findings support bevacizumab with S-1 and irinotecan combo as first-line regimen for mCRC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Updated TRICOLORE findings support bevacizumab with S-1 and irinotecan combo as first-line regimen for mCRC
User login
Username
Password
Reset your password
Type
Lead
score
Edit Tags